STACEY GOURDOUX: Open Payments
NPI 1477584118 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,923 in 155 payments from 28 companies in 2025. Trend: 2023 $3,427 · 2024 $3,588 · 2025 $3,923
Food & beverage: $3,823Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $662 |
| GENZYME CORPORATION | 19 | $517 |
| GlaxoSmithKline, LLC. | 16 | $310 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $216 |
| United Therapeutics Corporation | 7 | $212 |
| Regeneron Healthcare Solutions, Inc. | 6 | $199 |
| Insmed, Inc. | 6 | $187 |
| Verona Pharma, Inc. | 5 | $158 |
| Electromed, Inc. | 20 | $152 |
| Inspire Medical Systems, Inc. | 1 | $146 |
Products named: DUPIXENT, TEZSPIRE, TRELEGY ELLIPTA, Arikayce, Ohtuvayre, SMARTVEST, INSPIRE, LUMRYZ.
Industry payments across AZ — which companies pay providers there.
